LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4831 | 4267 | 1.1327 | 1.1447 |
MCF7 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2373 | 4267 | 0.5560 | 0.4399 |
MCF7 | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4203 | 4267 | 0.9846 | 0.9821 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3513 | 4267 | 0.8246 | 0.7956 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2603 | 4267 | 0.6116 | 0.5180 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1706 | 4267 | 0.4006 | 0.1983 |
MCF7 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1446 | 4267 | 0.3389 | 0.0915 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1371 | 4267 | 0.3216 | 0.0600 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1235 | 883 | 4267 | 0.2073 | -0.1712 |
MCF7 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4382 | 4267 | 1.0253 | 1.0258 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4851 | 4267 | 1.1371 | 1.1490 |
MCF7 | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4641 | 4267 | 1.0866 | 1.0935 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4537 | 4267 | 1.0633 | 1.0695 |
MCF7 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3527 | 4267 | 0.8263 | 0.7970 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4829 | 4267 | 1.1306 | 1.1406 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2031 | 4267 | 0.4761 | 0.3201 |
MCF7 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4687 | 4267 | 1.0985 | 1.1079 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1273 | 4267 | 0.2988 | 0.0173 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4230 | 4267 | 0.9910 | 0.9888 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 999 | 4267 | 0.2344 | -0.1123 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1235 | 1972 | 4267 | 0.4623 | 0.2987 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3207 | 4267 | 0.7514 | 0.7040 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2830 | 4267 | 0.6631 | 0.5890 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3401 | 4267 | 0.7967 | 0.7604 |
MCF7 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3911 | 4267 | 0.9172 | 0.9059 |